ORBIMED ADVISORS LLC - 25 Jul 2025 SCHEDULE 13D/A Report for ImageneBio, Inc. COMMON STOCK (IKNA)

Filing Manager
ORBIMED ADVISORS LLC
Reporting Manager
ORBIMED ADVISORS LLC
Symbol
IKNA
Shares outstanding
11,181,416 shares
Disclosed Ownership
773,754 shares
Ownership
6.9%
Form type
SCHEDULE 13D/A
Filing time
30 Jul 2025, 21:28:19 UTC
Date of event
25 Jul 2025
Previous filing
18 Jun 2025

Sponsored

Quoteable Key Fact

"ORBIMED ADVISORS LLC disclosed 6.9% ownership in ImageneBio, Inc. COMMON STOCK (IKNA) on 25 Jul 2025."

Quick Takeaways

  • ORBIMED ADVISORS LLC filed SCHEDULE 13D/A for ImageneBio, Inc. COMMON STOCK (IKNA).
  • Disclosed ownership: 6.9%.
  • Date of event: 25 Jul 2025.

What Changed

  • Previous schedule filing date: 18 Jun 2025.
  • Current filing was accepted on 30 Jul 2025, 21:28.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
ORBIMED ADVISORS LLC 6.9% 773,754 0 773,754 /s/ Carl L. Gordon Carl L. Gordon, Member 0001055951
ORBIMED CAPITAL GP VI LLC 6.7% 753,063 0 753,063 /s/ Carl L. Gordon Carl L. Gordon, Member of OrbiMed Advisors LLC 0001682115
OrbiMed Genesis GP LLC 0.19% 20,691 0 20,691 /s/ Carl L. Gordon Carl L. Gordon, Member of OrbiMed Advisors LLC 0001808744
ORBIMED CAPITAL LLC 1.2% 135,516 135,516 0 /s/ Carl L. Gordon Carl L. Gordon, Member 0001157524